- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07702799
Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer
Low-Residue Diet Versus Rectal Enema Before Laparoscopic Endometrial Cancer Surgery: A Prospective Randomized Controlled Trial
The goal of this clinical trial is to compare a standardized 3-day bowel preparation protocol with a rectal enema before laparoscopic surgery for endometrial cancer. The study will evaluate whether the dietary bowel preparation protocol can be used instead of a rectal enema while maintaining an adequate surgical view during surgery.
The main questions it aims to answer are:
- Can the dietary bowel preparation protocol provide surgical exposure comparable to a rectal enema?
- Can the dietary bowel preparation protocol reduce the minimum Trendelenburg position and pneumoperitoneum pressure required to obtain an adequate surgical view?
- Does either bowel preparation method cause more discomfort or side effects before surgery?
Researchers will compare a standardized 3-day bowel preparation protocol with a rectal enema before surgery.
Participants will:
- Be randomly assigned to receive either a standardized 3-day bowel preparation protocol or a rectal enema before surgery.
- Undergo standard laparoscopic surgery for endometrial cancer.
- Have surgical exposure, the minimum Trendelenburg position, the minimum pneumoperitoneum pressure, operative outcomes, postoperative recovery, and bowel preparation-related symptoms and discomfort assessed as part of routine clinical care.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Adequate bowel preparation is important for achieving optimal surgical exposure during laparoscopic surgery for endometrial cancer. Inadequate bowel preparation may impair visualization of the operative field, requiring steeper Trendelenburg positioning and higher pneumoperitoneum pressures, which may increase the physiological burden of surgery and affect operative performance.
Mechanical bowel preparation with rectal enema is commonly used before gynecologic surgery, although its routine use remains controversial because evidence supporting its clinical benefit is limited. A standardized 3-day bowel preparation protocol may improve patient tolerance while maintaining adequate surgical conditions. However, prospective randomized studies comparing these two approaches specifically in laparoscopic endometrial cancer surgery remain limited.
This prospective randomized controlled trial will compare a standardized 3-day bowel preparation protocol with a preoperative rectal enema before laparoscopic surgery for endometrial cancer. The primary objective is to determine whether the dietary bowel preparation protocol can provide surgical conditions comparable to those achieved with rectal enema.
In addition to subjective assessment of surgical exposure, the study will evaluate objective intraoperative parameters, including the minimum Trendelenburg position and the minimum pneumoperitoneum pressure required to maintain an adequate surgical view. Operative outcomes, postoperative recovery, patient tolerance of the bowel preparation methods, and bowel preparation-related symptoms will also be evaluated.
The findings of this study may help optimize preoperative bowel preparation strategies, reduce unnecessary patient burden, and support evidence-based perioperative care for patients undergoing laparoscopic surgery for endometrial cancer.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Mahmut Yassa, MD
- Telefonnummer: +90 539 663 54 84
- E-post: mahmut_yassa@hotmail.com
Studiesteder
-
-
-
Istanbul, Tyrkia (Türkiye)
- Rekruttering
- Başakşehir Çam and Sakura City Hospital
-
Ta kontakt med:
- mahmut yassa
- Telefonnummer: +905396635484
- E-post: mahmut_yassa@hotmail.com
-
Underetterforsker:
- Bora Taşpınar, MD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Female participants aged 18 to 90 years.
- Scheduled to undergo elective laparoscopic surgery for endometrial cancer.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- Planned open (abdominal) surgery.
- Known allergy or contraindication to sodium phosphate rectal enema.
- Age over 90 years.
- Refusal or inability to provide written informed consent.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Low-Residue Diet
Participants will follow a standardized 3-day bowel preparation protocol before surgery.
The protocol includes a low-residue diet on day 3 before surgery, a soft or pureed diet on day 2, and a clear liquid diet on the day before surgery
|
Participants will follow a standardized 3-day bowel preparation protocol consisting of a low-residue diet on day 3 before surgery, a soft or pureed diet on day 2, and a clear liquid diet on the day before surgery, with adequate hydration throughout the preparation period.
|
|
Aktiv komparator: Rectal Enema
Participants will receive a single sodium phosphate rectal enema approximately 12 hours before surgery according to the institutional bowel preparation protocol
|
Participants will receive a single sodium phosphate rectal enema approximately 12 hours before surgery according to the manufacturer's instructions and the institutional bowel preparation protocol.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Intraoperative Visual Index Score
Tidsramme: Intraoperatively, after pneumoperitoneum establishment and placement of the camera trocar and one lateral ancillary trocar
|
Surgical exposure will be assessed intraoperatively using the Visual Index score after establishment of pneumoperitoneum and placement of the camera trocar and one lateral ancillary trocar.
The score ranges from 0 to 2, where 0 indicates inadequate visualization despite bowel retraction with one grasper, 1 indicates adequate visualization requiring bowel retraction with one grasper, and 2 indicates adequate visualization without bowel retraction.
Higher scores indicate better surgical exposure.
|
Intraoperatively, after pneumoperitoneum establishment and placement of the camera trocar and one lateral ancillary trocar
|
|
Minimum Trendelenburg Position Required for Adequate Surgical Exposure
Tidsramme: Intraoperatively
|
The minimum Trendelenburg angle (degrees) required to achieve adequate visualization of the pelvis will be recorded intraoperatively using the predefined assessment protocol.
|
Intraoperatively
|
|
Minimum Pneumoperitoneum Pressure Required for Adequate Surgical Exposure
Tidsramme: Intraoperatively
|
The minimum pneumoperitoneum pressure (mmHg) required to achieve adequate visualization of the pelvis will be recorded intraoperatively using the predefined assessment protocol.
|
Intraoperatively
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Operative Time
Tidsramme: During surgery
|
Total operative time measured from skin incision to skin closure, recorded in minutes.
|
During surgery
|
|
Length of Hospital Stay
Tidsramme: At hospital discharge, assessed up to 30 days after surgery
|
Length of postoperative hospital stay, measured in days from surgery until hospital discharge.
|
At hospital discharge, assessed up to 30 days after surgery
|
|
Time to First Flatus
Tidsramme: From completion of surgery until the first documented passage of flatus, assessed up to 7 postoperative days
|
Time from completion of surgery to the first documented passage of flatus, measured in hours.
The occurrence and timing of first flatus will be assessed during daily postoperative visits until the event occurs or until hospital discharge.
|
From completion of surgery until the first documented passage of flatus, assessed up to 7 postoperative days
|
|
Patient Tolerance of Bowel Preparation
Tidsramme: From preoperative bowel preparation until postoperative day 1
|
Patient tolerance will be assessed using completion of the assigned bowel preparation protocol, willingness to repeat the same preparation method in a future surgery, postoperative pain score, and bowel preparation-related symptoms.
Symptoms will include nausea, overall discomfort, headache, insomnia, thirst, abdominal cramps, weakness, and fatigue, each assessed using a 0-10 numeric rating scale, where 0 indicates no symptom and 10 indicates the worst possible symptom.
|
From preoperative bowel preparation until postoperative day 1
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: MAHMUT YASSA, MD, Başakşehir Çam & Sakura City Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Kjønnssykdommer
- Urogenitale neoplasmer
- Neoplasmer etter nettsted
- Neoplasmer
- Kvinnelige urogenitale sykdommer
- Kvinnelige urogenitale sykdommer og graviditetskomplikasjoner
- Sykdommer i fordøyelsessystemet
- Livmorsykdommer
- Kjønnssykdommer, kvinner
- Genitale neoplasmer, kvinnelige
- Uterine neoplasmer
- Peritoneale sykdommer
- Pneumoperitoneum
- Endometriale neoplasmer
Andre studie-ID-numre
- ENDO-DIET-RCT-2026
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .